W. Ian Lipkin
	(Director, Center for Infection and Immunity, Columbia University, USA) http://cii.columbia.edu/team/lipkin.html

W. Ian Lipkin, MD, is the John Snow Professor of Epidemiology and Director of the Center for Infection and Immunity in the Mailman School of Public Health, and Professor of Neurology and Pathology in the College of Physicians and Surgeons. He is Director of the Northeast Biodefense Center, the National Institutes of Health/National Institute for Allergy and Infectious Disease Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research representing New York, New Jersey and Connecticut; Principle Investigator of the Autism Birth Cohort, a longitudinal study of 100,000 women and children that examines gene-environment interactions, biomarkers and the trajectory of disease in neurodevelopmental disorders; and Director of the World Health Organization Collaborating Centre on Diagnostics, Surveillance and Immunotherapeutics for Emerging Infectious and Zoonotic Diseases. He is Special Advisor to the Minister of Science and Technology of China, and serves on the boards of the Guangzhou Institute for Biomedicine and Health, the Institut Pasteur de Shanghai, the Australian Biosecurity Cooperative Research Centre, 454 Life Sciences, Tetragenetics, Prosetta, and Akonni Corporations. His honors include NARSAD Young Investigator, NIH Clinical Investigator Development Award, Pew Scholar in the Biomedical Sciences, Japanese Human Science Foundation Visiting Professor, Columbia College of Physicians and Surgeons Visiting Bruenn Professor, University of California Irvine Louise Turner Arnold Chair in the Neurosciences, American Society of Microbiology Foundation Lecturer, University of California Irvine Distinguished Lecturer, Ellison Medical Foundation Senior Scholar in Global Infectious Disease, Millennium Commencement Speaker Sarah Lawrence College, Dalldorf Research Physician NYS Department of Health, Fellow of the New York Academy of Sciences, Distinguished Lecturer of the National Center for Infectious Diseases, Honorary and Founding Director Beijing Center for Infectious Diseases, Fellow of the American Society for Microbiology. Dr. Lipkin received a BA from Sarah Lawrence College in 1974, where he studied cultural anthropology, philosophy, and literature, and an MD from Rush Medical College in 1978. His postgraduate training included a Clerkship at the Queen Square Institute of Neurology in London, UK (1977-78); Internship in Medicine at the University of Pittsburgh (1978-79); Residency in Internal Medicine at the University of Washington (1979-81); Residency in Neurology at the University of California, San Francisco (1981-84); and Fellowship in Neurovirology (Michael Oldstone) and Neuroscience (Floyd Bloom and Michael Wilson) at The Scripps Research Institute in La Jolla (1984-1990). He joined the faculty of the University of California in 1990 as an Assistant Professor in the departments of Neurology, Anatomy and Neurobiology, and Microbiology and Molecular Genetics, and advanced to full professor in 1996. In 2001 Dr. Lipkin moved to Columbia University as Jerome L. and Dawn Greene Professor of Epidemiology, Neurology, and Pathology in the Mailman School of Public Health and the College of Physicians and Surgeons. In January 2008 he became director of the Center for Infection and Immunity and the John Snow Professor of Epidemiology. Among Dr. Lipkin’s contributions include the first description of autoimmune neurologic disease in HIV infection (Lipkin, Neurology, 1985); first demonstration that viral infection can alter behavior without overt pathology (Lipkin, Brain Res, 1988); first use of purely molecular methods (subtractive cDNA cloning) to identify an infectious agent (Lipkin, PNAS, 1989); invention of domain specific differential display and identification of West Nile virus as the cause of the epidemic encephalitis in North America in 1999 (Briese, Lancet 1999); invention and implementation of MassTag PCR, a novel multiplex diagnostic method for infectious diseases (Briese, Emerg Infect Dis, 2005); discovery and implication of a novel, unculturable rhinovirus in pneumonia (Lamson, J Infect Dis, 2005); establishment of the first comprehensive panmicrobial database (Palacios, Emerg Infect Dis, 2007); invention, validation and implementation of the first panmicrobial microarray (Palacios, Emerg Infect Dis, 2007); invention, validation and implementation of the first comprehensive respiratory microarray (Quan, J Clin Microbiol, 2007); optimization of high throughput sequencing for infectious disease diagnostics; the first use of high throughput pyrosequencing to investigate an agricultural epidemic (Colony Collapse Disorder, Cox-Foster, Science 2007); and the first use of high throughput pyrosequencing to investigate an outbreak of human disease (Palacios, New Engl J Med, 2008). Lipkin has discovered more than 30 viruses; assisted the US CDC, China CDC, USDA, US Dept of Defense and WHO in outbreaks of respiratory disease, hemorrhagic fever, meningoencephalitis and vaccine safety investigations; and served as an intermediary between the WHO and the Chinese government during the SARS outbreak of 2003, and co-directed SARS research efforts in China with now Minister of Health Chen Zhu. He has trained 13 graduate students, 27 postdoctoral fellows, and under the auspices of the WHO and the NIH trained more than 30 investigators from 17 countries in methods for pathogen surveillance and discovery. As director of the Northeast Biodefense Center he coordinates activities of 28 academic institutions and more than 200 investigators in basic and translational research efforts focused on emerging infectious diseases.